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Computed Tomographic (CT) screening for lung cancer
remains controversial, although the National Lung
Screening Trial (NLST) found that low dose CT
(LDCT) reduced lung cancer mortality by about 20%
[1], the high rate of indeterminate and false positive
lung nodules was worrying.
The diagnostic work-up of CT nodules considers size
(diameter or volume), characteristics (density, morphol-
ogy, homogeneity) and volume doubling time (VDT), but
several studies have investigated the ability of positron
emission tomography (PET) to characterize nodules,
although its role in diagnostic algorithms for screening-
detected nodules has not been defined.
The first PET study with [18F]fluorodeoxyglucose to
characterize indeterminate nodules outside screening was
published in 2001 [2]. In a previous study on PET-CT at
baseline screening, we found an overall sensitivity of 88%
for diagnosing malignancy, while for solid nodules >10
mm, sensitivity was 100%, suggesting PET-CT as an alter-
native to invasive procedures in the screening setting [3].
When assessing the ability of PET-CT to diagnose indeter-
minate nodules detected during the subsequent years of
the screening and analyzing 383 PET-CT examinations
performed over 6 study years of screening, the sensitivity,
specificity and accuracy of visually evaluated PET-CT, in
distinguishing benign from malignant nodules, were 64%,
89% and 76% respectively. PET performance varied with
nodule diameter (accuracy increased from 70% for nodules
<10 mm to 82% for nodules ≥15 mm) and nodule type
(accuracy ranged from 88% for solid nodules to 46% for
non-solid nodules).
We do not use FNAB routinely in our screening pro-
tocol. Typically we proceed to surgery when nodule
characteristics, including VDT, often backed up by
PET-CT, indicate malignancy. The disadvantage is that
a preoperative pathological diagnosis is not available
and a wedge resection with frozen section examination
is required before radical surgery.
Nodules on PET-CT are commonly evaluated by semi-
quantitative SUVbw max, which is operator independent,
as well as by visual assessment of uptake by the nuclear
medicine physician, whose experience can markedly influ-
ence the result. In our study we evaluated both methods
and found visual assessment afforded higher accuracy
(76%) than any SUV threshold with a good compromise
between sensitivity (64%) and specificity (89%); while
increasing the threshold from 1.5 to 2.5 decreased sensitiv-
ity (67% to 51%) and increased specificity (80% to 91%).
To conclude, PET-CT has high NPV for solid nodules
≥15 mm, and high PPV for sub-solid nodules <10 mm,
justifying its inclusion in the diagnostic work-up of
indeterminate nodules identified on LDCT screening. It
is more useful for nodules detected at baseline, while
sensitivity is low for sub-solid nodules and nodules
discovered after baseline: for these other diagnostic
modalities, particularly VDT, are more useful.
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